Kirksville, MONCT07358364Now EnrollingIRB Ready

Chronic Spontaneous Urticaria Clinical Trial in Kirksville, MO

Access cutting-edge chronic spontaneous urticaria treatment through this clinical trial at a research site in Kirksville. Study-provided care at no cost to qualified participants.

Sponsored by Novartis Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Kirksville location

Preparing your pre-screening questions…

Expert Care in Kirksville

Access chronic spontaneous urticaria specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic spontaneous urticaria treatment provided free

Apply for This Kirksville Location

Check if you qualify for this chronic spontaneous urticaria clinical trial in Kirksville, MO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Kirksville

    Convenient for MO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Kirksville site if eligible
  4. 4Begin participation

About This Chronic Spontaneous Urticaria Study in Kirksville

Prospective, multi-country, non-interventional study in patients with CSU where the treatment decision prior enrolment has been made to either escalate current sgH1-AHs treatment or escalate/switch current treatment to remibrutinib. The primary aim of this study is to gather real-world effectiveness and safety data for remibrutinib, a new treatment option, covering a broader, real-world clinical practice population.

Sponsor: Novartis Pharmaceuticals

Who Can Participate

Inclusion Criteria

Patients with a confirmed diagnosis of primary CSU by the treating physician.
Aged at least 18 years on the date of enrolment.
Written informed consent of the patient to participate in the study (according to country specifications) and willingness to complete full follow-up period of 24 months.
Cohort-specific observational inclusion criteria:
Cohort 1: Inadequate control of CSU despite licensed dose of sgH1-AH (no other pre-treatments permitted) and decision (independent of study enrolment) to escalate sgH1-AH treatment.
Cohort 2: Inadequate control of CSU despite licensed dose or escalated sgH1-AH(s) (no other pre-treatment with exception of first generation H1-AH permitted) with decision (independent of study enrolment) to switch to remibrutinib treatment as per local label.
Cohort 3: Any other treatment received in addition to H1-AH, any time during patients' CSU treatment history, with decision (independent of study enrolment) to switch to remibrutinib treatment as per local label. Note, occasional steroid rescue medication is out of scope for cohort definition. If a patient had been on continuous steroids for at least three weeks during treatment history, they will be included in cohort 3. Note: Candidate patients must not have initiated the next escalated treatment step (i.e. up dosed AH for cohort 1, or remibrutinib for cohorts 2 and 3) prior to their enrolment to ensure the baseline visit captures their clinical status before treatment escalation.

Exclusion Criteria

Currently enrolled in a clinical trial or on any experimental treatment.
Patients within the safety follow-up phase of a previous interventional or non-interventional study.
Patients who received remibrutinib as an investigational medical product during a remibrutinib interventional study or MAP/PSDS at any time in the past.
Patients not capable or willing to continuously provide ePRO/eDiary data via electronic means throughout the duration of the study.
Patients who are treated with remibrutinib outside of the local label.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Kirksville?

Yes, this clinical trial (NCT07358364) has an active research site in Kirksville, MO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Spontaneous Urticaria Treatment Options in Kirksville, MO

If you're searching for chronic spontaneous urticaria treatment options in Kirksville, MO, this clinical trial (NCT07358364) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Kirksville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic spontaneous urticaria specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic spontaneous urticaria clinical trials near you to find additional studies recruiting in your area.

More Chronic Urticaria Trials in Kirksville, MO

See all chronic urticaria clinical trials recruiting in Kirksville — not just this study.

Browse Chronic Urticaria Trials in Kirksville →

Browse More Trials by Condition

Chronic Urticaria TrialsInterstitial Cystitis TrialsChronic Spontaneous Urticaria TrialsUrticaria TrialsAll Conditions →

Ready to Join in Kirksville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Kirksville, MO